Preliminary characterization of the procoagulant material in human ascites.
Disseminated intravascular coagulation invariably accompanies placement of peritoneovenous (LeVeen) shunts, which suggests that ascitic fluid contains procoagulant material capable of activating blood coagulation. In this study, we identified thrombogenic activity in human ascites and the hemostatic pathway by which it acts. Peritoneal fluid was removed percutaneously from patients with ascites due to various causes. Four fractions were prepared by centrifugation: cells, a low-speed, cell-free fluid, a high-speed supernatant, and the precipitate from the high-speed centrifugation. Cellular fractions from all ascitic fluids shortened a one-stage clotting time of normal pooled plasma by 68% in comparison with saline solution and endotoxin controls. Similarly, the cell-free fluids also shortened the clotting time of normal pooled plasma by 41%. The cellular and cell-free fractions shortened the clotting time of factor VIII-deficient plasma but failed to demonstrate procoagulant activity in factor VII-deficient plasma. These fractions had no effect on platelet aggregation or the platelet release reaction. The high-speed precipitate was dissociated by ethylenediaminetetra-acetate (EDTA) into fluid phase and precipitate, both of which demonstrated procoagulant activity. Furthermore, high-speed precipitate contained protein, phospholipid, and sterol in proportions similar to those of plasma membranes and contained membrane-bound vesicles as identified by means of electron microscopy. This material could be rendered inactive by heating to 100 degrees C for 2 minutes or by incubation with phospholipase C for 15 minutes. Finally, the ability of the high-speed precipitate to shorten the clotting time was prevented by preincubation with a monoclonal antibody, which is known to inhibit the procoagulant activity of human tissue factor. We suggest that several entities contribute to the procoagulant properties of human ascites, with procoagulant material deriving at least in part from peritoneal cells. The sedimentable procoagulant factor appears to be associated with cellular membranes or membrane fragments and is thromboplastin-like in its chemical composition, immunoreactivity, and substrate specificity.
D000328:Adult; D000368:Aged; D001202:Ascitic Fluid / Q000032:analysis*; D001779:Blood Coagulation Factors / Q000032:analysis* / Q000276:immunology; D001780:Blood Coagulation Tests; D002498:Centrifugation / Q000379:methods; D005168:Factor VII Deficiency / Q000097:blood; D005260:Female; D006467:Hemophilia A / Q000097:blood; D006801:Humans; D007962:Leukocytes / Q000032:analysis*; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D010974:Platelet Aggregation; D013925:Thromboplastin / Q000032:analysis
D001779:Blood Coagulation Factors; C045071:leukocyte procoagulant activity; D013925:Thromboplastin